Clinical Trial of a Telehealth Group-Based Intervention to Improve Mood in Underrepresented Individuals With Multiple Sclerosis: The Connect Trial (CONNECT)

CompletedNot a drug-phase studyMS (type not specified)NCT04943887

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

This trial finished 4 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • eSupport Health Weekly Group Sessions for PwMS

What it measured

Main measures

  • Adherence and completion

    through study completion, 20-40 weeks

    Quality of life (reported by participants)Feasibility

Other measures (1)

  • Hospital Anxiety and Depression Scale (HADS)

    through study completion, up to 40 weeks

    Mood and sleep

Who could take part

MS (type not specified) · 18 and over

Show the full criteria

Inclusion criteria

* Provision of signed and dated informed consent form (ICF) * Able to speak, read and understand English * Reside in the U.S. * Willingness to enroll as a member in eSupport Health * Stated willingness to comply with all study procedures and availability for the duration of the study * Willingness to adhere to the schedule of weekly online meetings with a minimum of 50% attendance (i.e., 6 of 12 meetings) * Males and females; Age 18+ * Self-reported diagnosis of multiple sclerosis including the date of the diagnosis (month and year) and the name of the diagnosing physician * Access to necessary resources for participating in a technology-based intervention (i.e., computer or tablet with a web camera and with a stable internet connection in a private setting) and demonstrated basic ability to use a computer by completing the electronic ICF completion process and meeting with the Study Coach via Zoom Telehealth secured platform at the Enrollment Session. * Provide identification to verify name, date of birth, and address.

Exclusion criteria

1. Current participation in another treatment or intervention study 2. Presence of a condition(s) or diagnosis, either physical or psychological that precludes participation such as significant brain injury and developmental disability 3. Current suicidal intent 4. Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Within-subject waitlist-control group design trial of eSupport health-coach moderated online support group participation to address mental health needs in persons with multiple sclerosis (PwMS) from historically underrepresented groups (i.e., Black and Latinx patients).

Loading reviews and guidelines…

History

    1. Started

      Aug 2021

    2. Main results due

      Jun 2022

    3. Finished

      Jun 2022

    Assembled by software from public sources.